Congress President
- Solange Peters, Lausanne, Switzerland
Scientific Co-Chairs
- Pasi Jänne, Boston, MA, USA
- Tony SK Mok, Hong Kong, China
Educational Chair
- Karin Jordan, Heidelberg, Germany
Scientific Sub-Committee (Track) Chairs
- Basic science: Ruth Plummer, Newcastle upon Tyne, UK
- Breast cancer, early stage: Sibylle Loibl, Neu-Isenburg, Germany
- Breast cancer, metastatic: Fabrice André, Villejuif, France
- CNS tumours: Emilie Le Rhun, Zurich, Switzerland
- Developmental therapeutics: Jordi Rodon, Houston, TX, USA
- Gastrointestinal tumours, colorectal: Julien Taieb, Paris, France
- Gastrointestinal tumours, non-colorectal: Stephen Chan, Hong Kong, China
- Genitourinary tumours, prostate: Eleni Efstathiou, Houston, TX, USA
- Genitourinary tumours, non-prostate: Thomas Powles, London, UK
- Gynaecological cancers: Cristiana Sessa, Bellinzona, Switzerland
- Haematological malignancies: Lena Specht, Copenhagen, Denmark
- Head and neck cancer: Kevin Harrington, London, UK
- Investigational immunotherapy: Pedro Romero, Lausanne, Switzerland
- Melanoma and other skin tumours: Omid Hamid, Los Angeles, CA, USA
- NETs and endocrine tumours: Rocio Garcia Carbonero, Madrid, Spain
- Non-metastatic NSCLC and other thoracic malignancies: Sanjay Popat, London, UK
- NSCLC, metastatic: Eddie Garon, Santa Monica, CA, USA
- Public policy: Elisabeth de Vries, Groningen, Netherlands
- Sarcoma: Javier Martin Broto, Seville, Spain
- Supportive and palliative care: Dorothy Keefe, Surry Hills, Australia
- Translational research: Daniel Tan, Singapore
ESMO Young Oncologists Committee (YOC)
- Christoph Oing, Hamburg, Germany (YOC Representative)
ESMO Patient Advocacy Working Group
- Vlad Voiculescu, Bucharest, Romania